Journal List HHS Author Manuscripts PMC library NLM provides access scientific literature Inclusion NLM database imply endorsement agreement contents NLM National Institutes Health Learn disclaimer Oncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi onc PMCID PMC NIHMSID NIHMS PMID Protein kinase C suppresses Kras mediated lung tumor formation activation p MAPKTGF signaling axis KS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Copyright notice publishers final edited version article available Oncogene Abstract Protein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo Keywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding Id INTRODUCTION Lung cancer leading cause cancer death United States estimated deaths annually Nonsmall cell lung cancer NSCLC accounts lung cancer diagnoses exhibits year survival rate underscoring importance understanding tumor promoting tumor suppressive signaling pathways drive NSCLC order identify potential therapeutic targets better treatment strategies Protein kinase C PKC represents family ten structurallyrelated lipiddependent serinethreonine kinases involved cellular proliferation differentiation survival identification PKC enzymes intracellular receptors tumor promoting phorbol esters provided suggestive causal link PKCs cellular transformation However relationship specific PKC isozymes cancer complex Individual PKC isozymes exhibit cell typespecific expression patterns complex signaling responses different subcellular localization substrate selection cofactor requirements result closely related PKC isozymes often distinct sometimes opposing roles cancer example PKC epsilon PKCe promotes cell proliferation survival overexpression PKC increases anchorageindependent cell growth tumorigenicity NIH cells contrast closely related isozyme PKC delta PKC promotes apoptosis inhibits NIH cell growth opposing roles PKCe PKCd also observed vivo Transgenic overexpression PKC epidermis promotes carcinogeninduced tumor formation whereas overexpression PKCd protective similar dichotomy function seen two atypical PKC isozymes PKC PKC shown atypical PKC oncogene NSCLC PKC overexpressed primary human NSCLC tumors result recurrent tumorspecific gene amplification PKC required anchorageindependent growth tumorigenesis human NSCLC cells vivo Additionally PKC required Kras mediated lung tumor initiation LSLKras model PKC also tumor promotive role colon ovarian leukemia pancreatic alveolar rhabdomyosarcoma cancers Given direct involvement PKC tumorigenesis developed novel therapeutic selectively target oncogenic PKC signaling currently evaluated clinic contrast highly related atypical PKC isozyme exhibits tumor suppressor activity multiple tissues including ovary lungs PKC alpha PKC particularly interesting exhibits tumor promoting tumor suppressive activity depending upon cellular context hepatocellular carcinoma cells PKC knockdown reduces cell growth migration invasion indicating tumor promotive role contrast activation PKC LNCaP prostate cancer cells induces increased apoptosis suggesting tumor suppressive activity Likewise genetic deletion PKC gene Prkc APC min mice increased tumor size reduced survival supporting tumor suppressive role colon role PKC lung cancer uncertain one hand selective activation PKC NSCLC cells phase results cellular senescence G cell cycle arrest whereas inhibition PKC G phase affect cell growth Therefore question still remains whether PKC tumor promoting tumor suppressive lung studies assessed role PKC lung tumorigenesis vivo address question assess role PKC three independent transgenic mouse models Krs driven lung tumorigenesis observed significant increase tumor number burden grade result PKC loss effect reflected enhanced expansion bronchioalveolar stem cells BASCs tumorinitiating cells models absence PKC PKCmediated tumor suppression involves activation p MAPKTGF signaling axis induces cellular growth arrest vitro enforces oncogeneinduced senescence OIS vivo RESULTS PKC expression frequent decreased human lung tumors first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomas Open separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials Methods PKC inhibits Krasdependent tumor initiation next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shown Open separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Loss PKC induces tumor progression bypass OIS Pathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c Open separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased Ki Loss PKC stimulates Krasmediated BASC expansion PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras Open separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSO p MAPK downstream effector PKC Krasinduced tumorigenesis p MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progression Open separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotype TGF mediates effects PKC loss BASC expansion TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signaling Open separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significant PKC regulates expression inhibitors DNA binding Id protein family results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growth Open separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO control Deletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesis data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesis Open separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSO DISCUSSION PKC family members implicated tumor promotion suppression review see Fields Murray Fields Gustafson conflicting reports regarding role PKCs general PKC specifically tumorigenesis progression disparate results may due differences cell tumortype function results obtained cell lines vitro versus transgenic animal models vivo specificity reagents used identify PKC function demonstrate PKC tumor suppressor vivo using three models Kras mediated lung cancer Genetic loss PKC murine lung results enhanced tumor growth progression carcinoma upon activation oncogenic Kras results consistent progressive loss PKC primary human NSCLC tumors advancing tumor stage PKCs capable phosphorylating Kras leading association mitochondrial BCLXL induction cellular apoptosis interest assess whether mechanism also contributes tumor suppressor effects observed studies focused Kras mediated lung adenocarcinoma human gene expression data indicate PKC frequently lost major forms NSCLC including lung squamous cell carcinoma harbor frequent Kras mutations Likewise PKC tumor suppressive role APC min intestinal tumorigenesis indicating tumor suppressive role PKC extends beyond Kras driven tumors Whether signaling mechanisms involved PKCmediated tumor suppression differ depending upon oncogenic drivers important area future investigation addition role tumor progression animal studies reveal additional unexpected role PKC tumor initiation LSLKrasPrkca mice exhibit enhanced expansion tumorinitiating BASCs effect appears due least part direct effect PKC loss growth Krastransformed BASCs Prkca mice harbor constitutive organismwide loss PKC exclude additional contribution PKC expressed tumorassociated stroma immune cells tumor suppression vivo analysis require complex animal models PKC expression conditionally controlled tissue timespecific manner Mechanistically data indicate PKC key role enforcement OIS vivo LSLKrasPrkca tumors exhibit reduced p InkA expression increase Ki staining progression adenocarcinoma consistent OIS bypass Interestingly observed regional coexpression PKC p InkA LSLKras tumors suggesting PKC loss Kras mediated tumorigenesis may represent intrinsic mechanism tumors overcome OIS findings PKC loss bear striking resemblance observed genetic loss p MAPK suggesting functional link genes Indeed mechanistic studies reveal p MAPK key downstream mediator PKC regulates tumor initiation least part control Kras mediated transformation tumorinitiating BASCs data consistent published reports demonstrating key role p MAPK OIS provide first demonstration PKCp MAPK signaling axis role OIS Kras mediated lung tumorigenesis vivo results also consistent finding PKC regulate senescence lung cancer cell lines vitro results provide compelling evidence PKCp MAPKTGF signaling axis drives tumor suppressive effects PKC Interestingly genetic loss PKC Krastransformed BASCs resulted small highly reproducible increase TGF expression effect though modest functionally relevant exogenous TGF mimic PKC loss inhibition TGF signaling reverses effect PKC loss BASC growth Therefore suppression TGF signaling key mechanism PKC inhibits lung cancer initiation progression Given modest change TGF mRNA abundance PKC likely also regulates aspects TGF signaling lung regard PKC facilitates internalization TGFR cell surface podocytes PKC induces expression TGF TGFR vascular smooth muscle cells data suggest involvement TGFR TGF signaling activation mediated PKC loss treatment TGFRALK selective inhibitor SB inhibits enhanced growth LSLKrasPrkca BASCs TGF like PKC either tumor promoting tumor suppressive depending cellular context Id family genes negativelyregulated PKC colon cancer PKC loss results increased expression Id turn regulate cyclin cell cycle progression Consistent findings show PKC negatively regulates Id BASCs effect PKC Id expression requires novel PKCp MAPKTGF signaling axis characterized report hypothesize PKC functions tumor suppressor lung least part inhibition expression Id genes turn mediate PKCinduced inhibition BASC lung tumor cell growth effect PKC loss Krasinduced lung tumorigenesis reminiscent phenotype observed WToverexpressing mice presence oncogenic Kras WToverexpressing mice exhibit enhanced Kras driven tumorigenesis mice lacking WT exhibit enhanced OIS PKC loss leads increased WT expression p MAPKTGFdependent pathway consistent finding WT expression regulated TGF signaling data suggest WT relevant downstream target involved mediating OIS bypass LSLKrasPrkca mice Analysis gene expression data sets revealed significant inverse relationship PKC WT Id expression primary human NSCLC tumors P Id P WT indicating relevance tumor PKC loss induction WT Id expression primary human NSCLC Finally results important implications therapeutic intervention strategies targeting PKC first isozymeselective PKC inhibitor enter clinical use base antisense oligonucleotide targeting PKC typeentreznucleotideattrstextLYtermid LY Aprinocarsen Aprinocarsen inhibited PKC expression exhibited antitumor activity nude mouse xenograft models However clinical benefit observed phase II clinical trials Aprinocarsen single agent ovarian cancer highgrade glioma Likewise large phase III clinical trial Aprinocarsen combination gemcitabine cisplatin advanced NSCLC failed demonstrate survival benefit difference response Therefore despite encouraging preclinical data PKC successful target cancer treatment current study others cited herein indicate PKC suppresses rather promotes tumorigenesis colon lung calling question rationale PKC inhibitors cancer therapy least tumor types MATERIALS METHODS Analysis publicly available gene expression data sets PKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo Kras models lung tumorigenesis Three independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use Committee Immunohistochemistry Immunofluorescence LSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKO BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TB BASC isolation ex vivo culture BASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USA Quantitative PCR analysis BASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNA Statistical analysis Differences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier method ACKNOWLEDGEMENTS authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer Research Footnotes CONFLICT INTEREST authors declare conflict interest REFERENCES Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar Journal List HHS Author Manuscripts PMC Journal List HHS Author Manuscripts PMC Journal List Journal List HHS Author Manuscripts HHS Author Manuscripts PMC library NLM provides access scientific literature Inclusion NLM database imply endorsement agreement contents NLM National Institutes Health Learn disclaimer Learn disclaimer Oncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi onc PMCID PMC NIHMSID NIHMS PMID Protein kinase C suppresses Kras mediated lung tumor formation activation p MAPKTGF signaling axis KS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Copyright notice publishers final edited version article available Oncogene Abstract Protein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo Keywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding Id INTRODUCTION Lung cancer leading cause cancer death United States estimated deaths annually Nonsmall cell lung cancer NSCLC accounts lung cancer diagnoses exhibits year survival rate underscoring importance understanding tumor promoting tumor suppressive signaling pathways drive NSCLC order identify potential therapeutic targets better treatment strategies Protein kinase C PKC represents family ten structurallyrelated lipiddependent serinethreonine kinases involved cellular proliferation differentiation survival identification PKC enzymes intracellular receptors tumor promoting phorbol esters provided suggestive causal link PKCs cellular transformation However relationship specific PKC isozymes cancer complex Individual PKC isozymes exhibit cell typespecific expression patterns complex signaling responses different subcellular localization substrate selection cofactor requirements result closely related PKC isozymes often distinct sometimes opposing roles cancer example PKC epsilon PKCe promotes cell proliferation survival overexpression PKC increases anchorageindependent cell growth tumorigenicity NIH cells contrast closely related isozyme PKC delta PKC promotes apoptosis inhibits NIH cell growth opposing roles PKCe PKCd also observed vivo Transgenic overexpression PKC epidermis promotes carcinogeninduced tumor formation whereas overexpression PKCd protective similar dichotomy function seen two atypical PKC isozymes PKC PKC shown atypical PKC oncogene NSCLC PKC overexpressed primary human NSCLC tumors result recurrent tumorspecific gene amplification PKC required anchorageindependent growth tumorigenesis human NSCLC cells vivo Additionally PKC required Kras mediated lung tumor initiation LSLKras model PKC also tumor promotive role colon ovarian leukemia pancreatic alveolar rhabdomyosarcoma cancers Given direct involvement PKC tumorigenesis developed novel therapeutic selectively target oncogenic PKC signaling currently evaluated clinic contrast highly related atypical PKC isozyme exhibits tumor suppressor activity multiple tissues including ovary lungs PKC alpha PKC particularly interesting exhibits tumor promoting tumor suppressive activity depending upon cellular context hepatocellular carcinoma cells PKC knockdown reduces cell growth migration invasion indicating tumor promotive role contrast activation PKC LNCaP prostate cancer cells induces increased apoptosis suggesting tumor suppressive activity Likewise genetic deletion PKC gene Prkc APC min mice increased tumor size reduced survival supporting tumor suppressive role colon role PKC lung cancer uncertain one hand selective activation PKC NSCLC cells phase results cellular senescence G cell cycle arrest whereas inhibition PKC G phase affect cell growth Therefore question still remains whether PKC tumor promoting tumor suppressive lung studies assessed role PKC lung tumorigenesis vivo address question assess role PKC three independent transgenic mouse models Krs driven lung tumorigenesis observed significant increase tumor number burden grade result PKC loss effect reflected enhanced expansion bronchioalveolar stem cells BASCs tumorinitiating cells models absence PKC PKCmediated tumor suppression involves activation p MAPKTGF signaling axis induces cellular growth arrest vitro enforces oncogeneinduced senescence OIS vivo RESULTS PKC expression frequent decreased human lung tumors first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomas Open separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials Methods PKC inhibits Krasdependent tumor initiation next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shown Open separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Loss PKC induces tumor progression bypass OIS Pathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c Open separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased Ki Loss PKC stimulates Krasmediated BASC expansion PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras Open separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSO p MAPK downstream effector PKC Krasinduced tumorigenesis p MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progression Open separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotype TGF mediates effects PKC loss BASC expansion TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signaling Open separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significant PKC regulates expression inhibitors DNA binding Id protein family results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growth Open separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO control Deletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesis data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesis Open separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSO DISCUSSION PKC family members implicated tumor promotion suppression review see Fields Murray Fields Gustafson conflicting reports regarding role PKCs general PKC specifically tumorigenesis progression disparate results may due differences cell tumortype function results obtained cell lines vitro versus transgenic animal models vivo specificity reagents used identify PKC function demonstrate PKC tumor suppressor vivo using three models Kras mediated lung cancer Genetic loss PKC murine lung results enhanced tumor growth progression carcinoma upon activation oncogenic Kras results consistent progressive loss PKC primary human NSCLC tumors advancing tumor stage PKCs capable phosphorylating Kras leading association mitochondrial BCLXL induction cellular apoptosis interest assess whether mechanism also contributes tumor suppressor effects observed studies focused Kras mediated lung adenocarcinoma human gene expression data indicate PKC frequently lost major forms NSCLC including lung squamous cell carcinoma harbor frequent Kras mutations Likewise PKC tumor suppressive role APC min intestinal tumorigenesis indicating tumor suppressive role PKC extends beyond Kras driven tumors Whether signaling mechanisms involved PKCmediated tumor suppression differ depending upon oncogenic drivers important area future investigation addition role tumor progression animal studies reveal additional unexpected role PKC tumor initiation LSLKrasPrkca mice exhibit enhanced expansion tumorinitiating BASCs effect appears due least part direct effect PKC loss growth Krastransformed BASCs Prkca mice harbor constitutive organismwide loss PKC exclude additional contribution PKC expressed tumorassociated stroma immune cells tumor suppression vivo analysis require complex animal models PKC expression conditionally controlled tissue timespecific manner Mechanistically data indicate PKC key role enforcement OIS vivo LSLKrasPrkca tumors exhibit reduced p InkA expression increase Ki staining progression adenocarcinoma consistent OIS bypass Interestingly observed regional coexpression PKC p InkA LSLKras tumors suggesting PKC loss Kras mediated tumorigenesis may represent intrinsic mechanism tumors overcome OIS findings PKC loss bear striking resemblance observed genetic loss p MAPK suggesting functional link genes Indeed mechanistic studies reveal p MAPK key downstream mediator PKC regulates tumor initiation least part control Kras mediated transformation tumorinitiating BASCs data consistent published reports demonstrating key role p MAPK OIS provide first demonstration PKCp MAPK signaling axis role OIS Kras mediated lung tumorigenesis vivo results also consistent finding PKC regulate senescence lung cancer cell lines vitro results provide compelling evidence PKCp MAPKTGF signaling axis drives tumor suppressive effects PKC Interestingly genetic loss PKC Krastransformed BASCs resulted small highly reproducible increase TGF expression effect though modest functionally relevant exogenous TGF mimic PKC loss inhibition TGF signaling reverses effect PKC loss BASC growth Therefore suppression TGF signaling key mechanism PKC inhibits lung cancer initiation progression Given modest change TGF mRNA abundance PKC likely also regulates aspects TGF signaling lung regard PKC facilitates internalization TGFR cell surface podocytes PKC induces expression TGF TGFR vascular smooth muscle cells data suggest involvement TGFR TGF signaling activation mediated PKC loss treatment TGFRALK selective inhibitor SB inhibits enhanced growth LSLKrasPrkca BASCs TGF like PKC either tumor promoting tumor suppressive depending cellular context Id family genes negativelyregulated PKC colon cancer PKC loss results increased expression Id turn regulate cyclin cell cycle progression Consistent findings show PKC negatively regulates Id BASCs effect PKC Id expression requires novel PKCp MAPKTGF signaling axis characterized report hypothesize PKC functions tumor suppressor lung least part inhibition expression Id genes turn mediate PKCinduced inhibition BASC lung tumor cell growth effect PKC loss Krasinduced lung tumorigenesis reminiscent phenotype observed WToverexpressing mice presence oncogenic Kras WToverexpressing mice exhibit enhanced Kras driven tumorigenesis mice lacking WT exhibit enhanced OIS PKC loss leads increased WT expression p MAPKTGFdependent pathway consistent finding WT expression regulated TGF signaling data suggest WT relevant downstream target involved mediating OIS bypass LSLKrasPrkca mice Analysis gene expression data sets revealed significant inverse relationship PKC WT Id expression primary human NSCLC tumors P Id P WT indicating relevance tumor PKC loss induction WT Id expression primary human NSCLC Finally results important implications therapeutic intervention strategies targeting PKC first isozymeselective PKC inhibitor enter clinical use base antisense oligonucleotide targeting PKC typeentreznucleotideattrstextLYtermid LY Aprinocarsen Aprinocarsen inhibited PKC expression exhibited antitumor activity nude mouse xenograft models However clinical benefit observed phase II clinical trials Aprinocarsen single agent ovarian cancer highgrade glioma Likewise large phase III clinical trial Aprinocarsen combination gemcitabine cisplatin advanced NSCLC failed demonstrate survival benefit difference response Therefore despite encouraging preclinical data PKC successful target cancer treatment current study others cited herein indicate PKC suppresses rather promotes tumorigenesis colon lung calling question rationale PKC inhibitors cancer therapy least tumor types MATERIALS METHODS Analysis publicly available gene expression data sets PKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo Kras models lung tumorigenesis Three independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use Committee Immunohistochemistry Immunofluorescence LSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKO BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TB BASC isolation ex vivo culture BASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USA Quantitative PCR analysis BASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNA Statistical analysis Differences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier method ACKNOWLEDGEMENTS authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer Research Footnotes CONFLICT INTEREST authors declare conflict interest REFERENCES Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar Oncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi onc PMCID PMC NIHMSID NIHMS PMID Protein kinase C suppresses Kras mediated lung tumor formation activation p MAPKTGF signaling axis KS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Copyright notice publishers final edited version article available Oncogene Abstract Protein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo Keywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding Id INTRODUCTION Lung cancer leading cause cancer death United States estimated deaths annually Nonsmall cell lung cancer NSCLC accounts lung cancer diagnoses exhibits year survival rate underscoring importance understanding tumor promoting tumor suppressive signaling pathways drive NSCLC order identify potential therapeutic targets better treatment strategies Protein kinase C PKC represents family ten structurallyrelated lipiddependent serinethreonine kinases involved cellular proliferation differentiation survival identification PKC enzymes intracellular receptors tumor promoting phorbol esters provided suggestive causal link PKCs cellular transformation However relationship specific PKC isozymes cancer complex Individual PKC isozymes exhibit cell typespecific expression patterns complex signaling responses different subcellular localization substrate selection cofactor requirements result closely related PKC isozymes often distinct sometimes opposing roles cancer example PKC epsilon PKCe promotes cell proliferation survival overexpression PKC increases anchorageindependent cell growth tumorigenicity NIH cells contrast closely related isozyme PKC delta PKC promotes apoptosis inhibits NIH cell growth opposing roles PKCe PKCd also observed vivo Transgenic overexpression PKC epidermis promotes carcinogeninduced tumor formation whereas overexpression PKCd protective similar dichotomy function seen two atypical PKC isozymes PKC PKC shown atypical PKC oncogene NSCLC PKC overexpressed primary human NSCLC tumors result recurrent tumorspecific gene amplification PKC required anchorageindependent growth tumorigenesis human NSCLC cells vivo Additionally PKC required Kras mediated lung tumor initiation LSLKras model PKC also tumor promotive role colon ovarian leukemia pancreatic alveolar rhabdomyosarcoma cancers Given direct involvement PKC tumorigenesis developed novel therapeutic selectively target oncogenic PKC signaling currently evaluated clinic contrast highly related atypical PKC isozyme exhibits tumor suppressor activity multiple tissues including ovary lungs PKC alpha PKC particularly interesting exhibits tumor promoting tumor suppressive activity depending upon cellular context hepatocellular carcinoma cells PKC knockdown reduces cell growth migration invasion indicating tumor promotive role contrast activation PKC LNCaP prostate cancer cells induces increased apoptosis suggesting tumor suppressive activity Likewise genetic deletion PKC gene Prkc APC min mice increased tumor size reduced survival supporting tumor suppressive role colon role PKC lung cancer uncertain one hand selective activation PKC NSCLC cells phase results cellular senescence G cell cycle arrest whereas inhibition PKC G phase affect cell growth Therefore question still remains whether PKC tumor promoting tumor suppressive lung studies assessed role PKC lung tumorigenesis vivo address question assess role PKC three independent transgenic mouse models Krs driven lung tumorigenesis observed significant increase tumor number burden grade result PKC loss effect reflected enhanced expansion bronchioalveolar stem cells BASCs tumorinitiating cells models absence PKC PKCmediated tumor suppression involves activation p MAPKTGF signaling axis induces cellular growth arrest vitro enforces oncogeneinduced senescence OIS vivo RESULTS PKC expression frequent decreased human lung tumors first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomas Open separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials Methods PKC inhibits Krasdependent tumor initiation next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shown Open separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Loss PKC induces tumor progression bypass OIS Pathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c Open separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased Ki Loss PKC stimulates Krasmediated BASC expansion PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras Open separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSO p MAPK downstream effector PKC Krasinduced tumorigenesis p MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progression Open separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotype TGF mediates effects PKC loss BASC expansion TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signaling Open separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significant PKC regulates expression inhibitors DNA binding Id protein family results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growth Open separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO control Deletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesis data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesis Open separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSO DISCUSSION PKC family members implicated tumor promotion suppression review see Fields Murray Fields Gustafson conflicting reports regarding role PKCs general PKC specifically tumorigenesis progression disparate results may due differences cell tumortype function results obtained cell lines vitro versus transgenic animal models vivo specificity reagents used identify PKC function demonstrate PKC tumor suppressor vivo using three models Kras mediated lung cancer Genetic loss PKC murine lung results enhanced tumor growth progression carcinoma upon activation oncogenic Kras results consistent progressive loss PKC primary human NSCLC tumors advancing tumor stage PKCs capable phosphorylating Kras leading association mitochondrial BCLXL induction cellular apoptosis interest assess whether mechanism also contributes tumor suppressor effects observed studies focused Kras mediated lung adenocarcinoma human gene expression data indicate PKC frequently lost major forms NSCLC including lung squamous cell carcinoma harbor frequent Kras mutations Likewise PKC tumor suppressive role APC min intestinal tumorigenesis indicating tumor suppressive role PKC extends beyond Kras driven tumors Whether signaling mechanisms involved PKCmediated tumor suppression differ depending upon oncogenic drivers important area future investigation addition role tumor progression animal studies reveal additional unexpected role PKC tumor initiation LSLKrasPrkca mice exhibit enhanced expansion tumorinitiating BASCs effect appears due least part direct effect PKC loss growth Krastransformed BASCs Prkca mice harbor constitutive organismwide loss PKC exclude additional contribution PKC expressed tumorassociated stroma immune cells tumor suppression vivo analysis require complex animal models PKC expression conditionally controlled tissue timespecific manner Mechanistically data indicate PKC key role enforcement OIS vivo LSLKrasPrkca tumors exhibit reduced p InkA expression increase Ki staining progression adenocarcinoma consistent OIS bypass Interestingly observed regional coexpression PKC p InkA LSLKras tumors suggesting PKC loss Kras mediated tumorigenesis may represent intrinsic mechanism tumors overcome OIS findings PKC loss bear striking resemblance observed genetic loss p MAPK suggesting functional link genes Indeed mechanistic studies reveal p MAPK key downstream mediator PKC regulates tumor initiation least part control Kras mediated transformation tumorinitiating BASCs data consistent published reports demonstrating key role p MAPK OIS provide first demonstration PKCp MAPK signaling axis role OIS Kras mediated lung tumorigenesis vivo results also consistent finding PKC regulate senescence lung cancer cell lines vitro results provide compelling evidence PKCp MAPKTGF signaling axis drives tumor suppressive effects PKC Interestingly genetic loss PKC Krastransformed BASCs resulted small highly reproducible increase TGF expression effect though modest functionally relevant exogenous TGF mimic PKC loss inhibition TGF signaling reverses effect PKC loss BASC growth Therefore suppression TGF signaling key mechanism PKC inhibits lung cancer initiation progression Given modest change TGF mRNA abundance PKC likely also regulates aspects TGF signaling lung regard PKC facilitates internalization TGFR cell surface podocytes PKC induces expression TGF TGFR vascular smooth muscle cells data suggest involvement TGFR TGF signaling activation mediated PKC loss treatment TGFRALK selective inhibitor SB inhibits enhanced growth LSLKrasPrkca BASCs TGF like PKC either tumor promoting tumor suppressive depending cellular context Id family genes negativelyregulated PKC colon cancer PKC loss results increased expression Id turn regulate cyclin cell cycle progression Consistent findings show PKC negatively regulates Id BASCs effect PKC Id expression requires novel PKCp MAPKTGF signaling axis characterized report hypothesize PKC functions tumor suppressor lung least part inhibition expression Id genes turn mediate PKCinduced inhibition BASC lung tumor cell growth effect PKC loss Krasinduced lung tumorigenesis reminiscent phenotype observed WToverexpressing mice presence oncogenic Kras WToverexpressing mice exhibit enhanced Kras driven tumorigenesis mice lacking WT exhibit enhanced OIS PKC loss leads increased WT expression p MAPKTGFdependent pathway consistent finding WT expression regulated TGF signaling data suggest WT relevant downstream target involved mediating OIS bypass LSLKrasPrkca mice Analysis gene expression data sets revealed significant inverse relationship PKC WT Id expression primary human NSCLC tumors P Id P WT indicating relevance tumor PKC loss induction WT Id expression primary human NSCLC Finally results important implications therapeutic intervention strategies targeting PKC first isozymeselective PKC inhibitor enter clinical use base antisense oligonucleotide targeting PKC typeentreznucleotideattrstextLYtermid LY Aprinocarsen Aprinocarsen inhibited PKC expression exhibited antitumor activity nude mouse xenograft models However clinical benefit observed phase II clinical trials Aprinocarsen single agent ovarian cancer highgrade glioma Likewise large phase III clinical trial Aprinocarsen combination gemcitabine cisplatin advanced NSCLC failed demonstrate survival benefit difference response Therefore despite encouraging preclinical data PKC successful target cancer treatment current study others cited herein indicate PKC suppresses rather promotes tumorigenesis colon lung calling question rationale PKC inhibitors cancer therapy least tumor types MATERIALS METHODS Analysis publicly available gene expression data sets PKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo Kras models lung tumorigenesis Three independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use Committee Immunohistochemistry Immunofluorescence LSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKO BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TB BASC isolation ex vivo culture BASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USA Quantitative PCR analysis BASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNA Statistical analysis Differences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier method ACKNOWLEDGEMENTS authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer Research Footnotes CONFLICT INTEREST authors declare conflict interest REFERENCES Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar Oncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi onc PMCID PMC NIHMSID NIHMS PMID Protein kinase C suppresses Kras mediated lung tumor formation activation p MAPKTGF signaling axis KS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Copyright notice publishers final edited version article available Oncogene Abstract Protein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo Keywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding Id INTRODUCTION Lung cancer leading cause cancer death United States estimated deaths annually Nonsmall cell lung cancer NSCLC accounts lung cancer diagnoses exhibits year survival rate underscoring importance understanding tumor promoting tumor suppressive signaling pathways drive NSCLC order identify potential therapeutic targets better treatment strategies Protein kinase C PKC represents family ten structurallyrelated lipiddependent serinethreonine kinases involved cellular proliferation differentiation survival identification PKC enzymes intracellular receptors tumor promoting phorbol esters provided suggestive causal link PKCs cellular transformation However relationship specific PKC isozymes cancer complex Individual PKC isozymes exhibit cell typespecific expression patterns complex signaling responses different subcellular localization substrate selection cofactor requirements result closely related PKC isozymes often distinct sometimes opposing roles cancer example PKC epsilon PKCe promotes cell proliferation survival overexpression PKC increases anchorageindependent cell growth tumorigenicity NIH cells contrast closely related isozyme PKC delta PKC promotes apoptosis inhibits NIH cell growth opposing roles PKCe PKCd also observed vivo Transgenic overexpression PKC epidermis promotes carcinogeninduced tumor formation whereas overexpression PKCd protective similar dichotomy function seen two atypical PKC isozymes PKC PKC shown atypical PKC oncogene NSCLC PKC overexpressed primary human NSCLC tumors result recurrent tumorspecific gene amplification PKC required anchorageindependent growth tumorigenesis human NSCLC cells vivo Additionally PKC required Kras mediated lung tumor initiation LSLKras model PKC also tumor promotive role colon ovarian leukemia pancreatic alveolar rhabdomyosarcoma cancers Given direct involvement PKC tumorigenesis developed novel therapeutic selectively target oncogenic PKC signaling currently evaluated clinic contrast highly related atypical PKC isozyme exhibits tumor suppressor activity multiple tissues including ovary lungs PKC alpha PKC particularly interesting exhibits tumor promoting tumor suppressive activity depending upon cellular context hepatocellular carcinoma cells PKC knockdown reduces cell growth migration invasion indicating tumor promotive role contrast activation PKC LNCaP prostate cancer cells induces increased apoptosis suggesting tumor suppressive activity Likewise genetic deletion PKC gene Prkc APC min mice increased tumor size reduced survival supporting tumor suppressive role colon role PKC lung cancer uncertain one hand selective activation PKC NSCLC cells phase results cellular senescence G cell cycle arrest whereas inhibition PKC G phase affect cell growth Therefore question still remains whether PKC tumor promoting tumor suppressive lung studies assessed role PKC lung tumorigenesis vivo address question assess role PKC three independent transgenic mouse models Krs driven lung tumorigenesis observed significant increase tumor number burden grade result PKC loss effect reflected enhanced expansion bronchioalveolar stem cells BASCs tumorinitiating cells models absence PKC PKCmediated tumor suppression involves activation p MAPKTGF signaling axis induces cellular growth arrest vitro enforces oncogeneinduced senescence OIS vivo RESULTS PKC expression frequent decreased human lung tumors first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomas Open separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials Methods PKC inhibits Krasdependent tumor initiation next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shown Open separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Loss PKC induces tumor progression bypass OIS Pathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c Open separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased Ki Loss PKC stimulates Krasmediated BASC expansion PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras Open separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSO p MAPK downstream effector PKC Krasinduced tumorigenesis p MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progression Open separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotype TGF mediates effects PKC loss BASC expansion TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signaling Open separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significant PKC regulates expression inhibitors DNA binding Id protein family results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growth Open separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO control Deletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesis data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesis Open separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSO DISCUSSION PKC family members implicated tumor promotion suppression review see Fields Murray Fields Gustafson conflicting reports regarding role PKCs general PKC specifically tumorigenesis progression disparate results may due differences cell tumortype function results obtained cell lines vitro versus transgenic animal models vivo specificity reagents used identify PKC function demonstrate PKC tumor suppressor vivo using three models Kras mediated lung cancer Genetic loss PKC murine lung results enhanced tumor growth progression carcinoma upon activation oncogenic Kras results consistent progressive loss PKC primary human NSCLC tumors advancing tumor stage PKCs capable phosphorylating Kras leading association mitochondrial BCLXL induction cellular apoptosis interest assess whether mechanism also contributes tumor suppressor effects observed studies focused Kras mediated lung adenocarcinoma human gene expression data indicate PKC frequently lost major forms NSCLC including lung squamous cell carcinoma harbor frequent Kras mutations Likewise PKC tumor suppressive role APC min intestinal tumorigenesis indicating tumor suppressive role PKC extends beyond Kras driven tumors Whether signaling mechanisms involved PKCmediated tumor suppression differ depending upon oncogenic drivers important area future investigation addition role tumor progression animal studies reveal additional unexpected role PKC tumor initiation LSLKrasPrkca mice exhibit enhanced expansion tumorinitiating BASCs effect appears due least part direct effect PKC loss growth Krastransformed BASCs Prkca mice harbor constitutive organismwide loss PKC exclude additional contribution PKC expressed tumorassociated stroma immune cells tumor suppression vivo analysis require complex animal models PKC expression conditionally controlled tissue timespecific manner Mechanistically data indicate PKC key role enforcement OIS vivo LSLKrasPrkca tumors exhibit reduced p InkA expression increase Ki staining progression adenocarcinoma consistent OIS bypass Interestingly observed regional coexpression PKC p InkA LSLKras tumors suggesting PKC loss Kras mediated tumorigenesis may represent intrinsic mechanism tumors overcome OIS findings PKC loss bear striking resemblance observed genetic loss p MAPK suggesting functional link genes Indeed mechanistic studies reveal p MAPK key downstream mediator PKC regulates tumor initiation least part control Kras mediated transformation tumorinitiating BASCs data consistent published reports demonstrating key role p MAPK OIS provide first demonstration PKCp MAPK signaling axis role OIS Kras mediated lung tumorigenesis vivo results also consistent finding PKC regulate senescence lung cancer cell lines vitro results provide compelling evidence PKCp MAPKTGF signaling axis drives tumor suppressive effects PKC Interestingly genetic loss PKC Krastransformed BASCs resulted small highly reproducible increase TGF expression effect though modest functionally relevant exogenous TGF mimic PKC loss inhibition TGF signaling reverses effect PKC loss BASC growth Therefore suppression TGF signaling key mechanism PKC inhibits lung cancer initiation progression Given modest change TGF mRNA abundance PKC likely also regulates aspects TGF signaling lung regard PKC facilitates internalization TGFR cell surface podocytes PKC induces expression TGF TGFR vascular smooth muscle cells data suggest involvement TGFR TGF signaling activation mediated PKC loss treatment TGFRALK selective inhibitor SB inhibits enhanced growth LSLKrasPrkca BASCs TGF like PKC either tumor promoting tumor suppressive depending cellular context Id family genes negativelyregulated PKC colon cancer PKC loss results increased expression Id turn regulate cyclin cell cycle progression Consistent findings show PKC negatively regulates Id BASCs effect PKC Id expression requires novel PKCp MAPKTGF signaling axis characterized report hypothesize PKC functions tumor suppressor lung least part inhibition expression Id genes turn mediate PKCinduced inhibition BASC lung tumor cell growth effect PKC loss Krasinduced lung tumorigenesis reminiscent phenotype observed WToverexpressing mice presence oncogenic Kras WToverexpressing mice exhibit enhanced Kras driven tumorigenesis mice lacking WT exhibit enhanced OIS PKC loss leads increased WT expression p MAPKTGFdependent pathway consistent finding WT expression regulated TGF signaling data suggest WT relevant downstream target involved mediating OIS bypass LSLKrasPrkca mice Analysis gene expression data sets revealed significant inverse relationship PKC WT Id expression primary human NSCLC tumors P Id P WT indicating relevance tumor PKC loss induction WT Id expression primary human NSCLC Finally results important implications therapeutic intervention strategies targeting PKC first isozymeselective PKC inhibitor enter clinical use base antisense oligonucleotide targeting PKC typeentreznucleotideattrstextLYtermid LY Aprinocarsen Aprinocarsen inhibited PKC expression exhibited antitumor activity nude mouse xenograft models However clinical benefit observed phase II clinical trials Aprinocarsen single agent ovarian cancer highgrade glioma Likewise large phase III clinical trial Aprinocarsen combination gemcitabine cisplatin advanced NSCLC failed demonstrate survival benefit difference response Therefore despite encouraging preclinical data PKC successful target cancer treatment current study others cited herein indicate PKC suppresses rather promotes tumorigenesis colon lung calling question rationale PKC inhibitors cancer therapy least tumor types MATERIALS METHODS Analysis publicly available gene expression data sets PKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo Kras models lung tumorigenesis Three independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use Committee Immunohistochemistry Immunofluorescence LSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKO BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TB BASC isolation ex vivo culture BASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USA Quantitative PCR analysis BASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNA Statistical analysis Differences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier method ACKNOWLEDGEMENTS authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer Research Footnotes CONFLICT INTEREST authors declare conflict interest REFERENCES Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar Oncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi onc PMCID PMC NIHMSID NIHMS PMID Protein kinase C suppresses Kras mediated lung tumor formation activation p MAPKTGF signaling axis KS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP Fields Author information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Copyright notice publishers final edited version article available OncogeneOncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi onc PMCID PMC NIHMSID NIHMS PMID Oncogene Author manuscript available PMC Apr Published final edited form Oncogene Apr Published online Apr doi oncOncogene Author manuscript available PMC Apr OncogenePublished final edited form asPublished final edited form asOncogene Apr Published online Apr doi oncOncogene Apr Oncogene Apr Published online Apr doi oncdoi oncPMCID PMC NIHMSID NIHMS PMID PMCID PMCPMCID PMCNIHMSID NIHMSNIHMSID NIHMSPMID Protein kinase C suppresses Kras mediated lung tumor formation activation p MAPKTGF signaling axisKrasKS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP FieldsKS Hill E Erdogan Khoor MP Walsh Leitges NR Murray AP Fields KS HillE ErdoganA KhoorMP WalshM LeitgesNR MurrayAP FieldsKS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS Hill E Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E Erdogan Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles Khoor MP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP Walsh Leitges Oslo Biotechnology Centre Oslo Norway Find articles Leitges NR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR Murray AP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP FieldsKS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles KS HillKS Hill Department Cancer Biology Mayo Clinic Jacksonville FL USAFind articles KS HillKS HillE Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles E ErdoganE Erdogan Department Cancer Biology Mayo Clinic Jacksonville FL USAFind articles E ErdoganE ErdoganA Khoor Department Pathology Mayo Clinic Jacksonville FL USA Find articles KhoorA Khoor Department Pathology Mayo Clinic Jacksonville FL USAFind articles KhoorA KhoorMP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles MP WalshMP Walsh Department Cancer Biology Mayo Clinic Jacksonville FL USAFind articles MP WalshMP WalshM Leitges Oslo Biotechnology Centre Oslo Norway Find articles LeitgesM Leitges Oslo Biotechnology Centre Oslo NorwayFind articles LeitgesM LeitgesNR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles NR MurrayNR Murray Department Cancer Biology Mayo Clinic Jacksonville FL USAFind articles NR MurrayNR MurrayAP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USA Find articles AP FieldsAP Fields Department Cancer Biology Mayo Clinic Jacksonville FL USAFind articles AP FieldsAP FieldsAuthor information Copyright License information Disclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Copyright notice Author information Copyright License information DisclaimerAuthor informationCopyright License informationDisclaimer Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo Norway Correspondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleif authors contributed equally work Department Cancer Biology Mayo Clinic Jacksonville FL USA Department Pathology Mayo Clinic Jacksonville FL USA Oslo Biotechnology Centre Oslo NorwayCorrespondence Dr AP Fields Department Cancer Biology Mayo Clinic Griffin Cancer Research Building Rm San Pablo Road Jacksonville FL USA udeoyamnalasdleifudeoyamnalasdleif authors contributed equally workCopyright notice Copyright notice Copyright noticeThe publishers final edited version article available OncogeneThe publishers final edited version article available OncogeneOncogeneAbstract Protein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo Keywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding IdAbstractProtein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo Protein kinase C alpha PKC activate pro antitumorigenic signaling depending upon cellular context investigated role PKC lung tumorigenesis vivo Gene expression data sets revealed primary human nonsmall lung cancers NSCLC express significantly decreased PKC levels indicating loss PKC expression recurrent event NSCLC evaluated functional relevance PKC loss lung tumorigenesis three murine lung adenocarcinoma models LSLKras LAKras urethane exposure Genetic deletion PKC resulted significant increase lung tumor number size burden grade bypass oncogeneinduced senescence progression adenoma carcinoma significant decrease survival vivo tumor promoting effect PKC loss reflected enhanced Krasmediated expansion bronchioalveolar stem cells BASCs putative tumorinitiating cells vitro vivo LSLKrasPrkca mice exhibited decrease phosphop MAPK BASCs vitro tumors vivo treatment LSLKras BASCs p inhibitor resulted increased colony size indistinguishable observed LSLKrasPrkca BASCs addition LSLKrasPrkca BASCs exhibited modest reproducible increase TGF mRNA addition exogenous TGF LSLKras BASCs results enhanced growth similar untreated BASCs LSLKrasPrkca mice Conversely TGFR inhibitor reversed effects PKC loss LSLKrasPrkca BASCs Finally identified inhibitors DNA binding Id Id Wilms Tumor potential downstream targets PKCdependent tumor suppressor activity vitro vivo conclude PKC suppresses tumor initiation progression least part PKCpMAPKTGF signaling axis regulates tumor cell proliferation Krasinduced senescence results provide first direct evidence PKC exhibits tumor suppressor activity lung vivo vivoLSLKras LAKrasin vivoin vitroin vivo LSLKrasPrkcain vitroin vivoLSLKrasLSLKrasPrkcaLSLKrasPrkcaLSLKrasLSLKrasPrkcaLSLKrasPrkcain vitroin vivoin vivoKeywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding IdKeywords tumor suppressor lung adenocarcinoma bronchioalveolar stem cells p MAPK Wilms Tumor gene inhibitors DNA Binding IdINTRODUCTION Lung cancer leading cause cancer death United States estimated deaths annually Nonsmall cell lung cancer NSCLC accounts lung cancer diagnoses exhibits year survival rate underscoring importance understanding tumor promoting tumor suppressive signaling pathways drive NSCLC order identify potential therapeutic targets better treatment strategies Protein kinase C PKC represents family ten structurallyrelated lipiddependent serinethreonine kinases involved cellular proliferation differentiation survival identification PKC enzymes intracellular receptors tumor promoting phorbol esters provided suggestive causal link PKCs cellular transformation However relationship specific PKC isozymes cancer complex Individual PKC isozymes exhibit cell typespecific expression patterns complex signaling responses different subcellular localization substrate selection cofactor requirements result closely related PKC isozymes often distinct sometimes opposing roles cancer example PKC epsilon PKCe promotes cell proliferation survival overexpression PKC increases anchorageindependent cell growth tumorigenicity NIH cells contrast closely related isozyme PKC delta PKC promotes apoptosis inhibits NIH cell growth opposing roles PKCe PKCd also observed vivo Transgenic overexpression PKC epidermis promotes carcinogeninduced tumor formation whereas overexpression PKCd protective similar dichotomy function seen two atypical PKC isozymes PKC PKC shown atypical PKC oncogene NSCLC PKC overexpressed primary human NSCLC tumors result recurrent tumorspecific gene amplification PKC required anchorageindependent growth tumorigenesis human NSCLC cells vivo Additionally PKC required Kras mediated lung tumor initiation LSLKras model PKC also tumor promotive role colon ovarian leukemia pancreatic alveolar rhabdomyosarcoma cancers Given direct involvement PKC tumorigenesis developed novel therapeutic selectively target oncogenic PKC signaling currently evaluated clinic contrast highly related atypical PKC isozyme exhibits tumor suppressor activity multiple tissues including ovary lungs PKC alpha PKC particularly interesting exhibits tumor promoting tumor suppressive activity depending upon cellular context hepatocellular carcinoma cells PKC knockdown reduces cell growth migration invasion indicating tumor promotive role contrast activation PKC LNCaP prostate cancer cells induces increased apoptosis suggesting tumor suppressive activity Likewise genetic deletion PKC gene Prkc APC min mice increased tumor size reduced survival supporting tumor suppressive role colon role PKC lung cancer uncertain one hand selective activation PKC NSCLC cells phase results cellular senescence G cell cycle arrest whereas inhibition PKC G phase affect cell growth Therefore question still remains whether PKC tumor promoting tumor suppressive lung studies assessed role PKC lung tumorigenesis vivo address question assess role PKC three independent transgenic mouse models Krs driven lung tumorigenesis observed significant increase tumor number burden grade result PKC loss effect reflected enhanced expansion bronchioalveolar stem cells BASCs tumorinitiating cells models absence PKC PKCmediated tumor suppression involves activation p MAPKTGF signaling axis induces cellular growth arrest vitro enforces oncogeneinduced senescence OIS vivo INTRODUCTIONLung cancer leading cause cancer death United States estimated deaths annually Nonsmall cell lung cancer NSCLC accounts lung cancer diagnoses exhibits year survival rate underscoring importance understanding tumor promoting tumor suppressive signaling pathways drive NSCLC order identify potential therapeutic targets better treatment strategiesProtein kinase C PKC represents family ten structurallyrelated lipiddependent serinethreonine kinases involved cellular proliferation differentiation survival identification PKC enzymes intracellular receptors tumor promoting phorbol esters provided suggestive causal link PKCs cellular transformation However relationship specific PKC isozymes cancer complex Individual PKC isozymes exhibit cell typespecific expression patterns complex signaling responses different subcellular localization substrate selection cofactor requirements result closely related PKC isozymes often distinct sometimes opposing roles cancer example PKC epsilon PKCe promotes cell proliferation survival overexpression PKC increases anchorageindependent cell growth tumorigenicity NIH cells contrast closely related isozyme PKC delta PKC promotes apoptosis inhibits NIH cell growth opposing roles PKCe PKCd also observed vivo Transgenic overexpression PKC epidermis promotes carcinogeninduced tumor formation whereas overexpression PKCd protective similar dichotomy function seen two atypical PKC isozymes PKC PKC shown atypical PKC oncogene NSCLC PKC overexpressed primary human NSCLC tumors result recurrent tumorspecific gene amplification PKC required anchorageindependent growth tumorigenesis human NSCLC cells vivo Additionally PKC required Kras mediated lung tumor initiation LSLKras model PKC also tumor promotive role colon ovarian leukemia pancreatic alveolar rhabdomyosarcoma cancers Given direct involvement PKC tumorigenesis developed novel therapeutic selectively target oncogenic PKC signaling currently evaluated clinic contrast highly related atypical PKC isozyme exhibits tumor suppressor activity multiple tissues including ovary lungs vivo KrasLSLKras PKC alpha PKC particularly interesting exhibits tumor promoting tumor suppressive activity depending upon cellular context hepatocellular carcinoma cells PKC knockdown reduces cell growth migration invasion indicating tumor promotive role contrast activation PKC LNCaP prostate cancer cells induces increased apoptosis suggesting tumor suppressive activity Likewise genetic deletion PKC gene Prkc APC min mice increased tumor size reduced survival supporting tumor suppressive role colon role PKC lung cancer uncertain one hand selective activation PKC NSCLC cells phase results cellular senescence G cell cycle arrest whereas inhibition PKC G phase affect cell growth Therefore question still remains whether PKC tumor promoting tumor suppressive lung studies assessed role PKC lung tumorigenesis vivo address question assess role PKC three independent transgenic mouse models Krs driven lung tumorigenesis observed significant increase tumor number burden grade result PKC loss effect reflected enhanced expansion bronchioalveolar stem cells BASCs tumorinitiating cells models absence PKC PKCmediated tumor suppression involves activation p MAPKTGF signaling axis induces cellular growth arrest vitro enforces oncogeneinduced senescence OIS vivo PrkcAPC minminin vivoKrsin vitroin vivoRESULTS PKC expression frequent decreased human lung tumors first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomas Open separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials Methods PKC inhibits Krasdependent tumor initiation next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shown Open separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Loss PKC induces tumor progression bypass OIS Pathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c Open separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased Ki Loss PKC stimulates Krasmediated BASC expansion PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras Open separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSO p MAPK downstream effector PKC Krasinduced tumorigenesis p MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progression Open separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotype TGF mediates effects PKC loss BASC expansion TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signaling Open separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significant PKC regulates expression inhibitors DNA binding Id protein family results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growth Open separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO control Deletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesis data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesis Open separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSORESULTSPKC expression frequent decreased human lung tumors first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomas Open separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials MethodsPKC expression frequent decreased human lung tumorsWe first analyzed PKC expression human NSCLC gene expression data sets NextBio database revealed PKC significantly downregulated adenocarcinoma squamous cell carcinoma large cell carcinoma three major NSCLC subtypes Figure Interestingly PKC loss increased tumor stage suggesting role tumor progression Immunohistochemistry confirmed loss PKC primary lung adenocarcinoma cells compared surrounding stroma Figure b Loss PKC also observed lung adenomas LSLKras mice Figure c LSLKras tumors PKC loss greater areas tumor others results consistent progressive PKC loss advanced tumor stage LSLKras lung tumors early stage adenomas Thus PKC loss occurs primary human NSCLC tumors LSLKras adenomasFigure aFigure aFigure bFigure bLSLKrasFigure cFigure cLSLKrasLSLKrasLSLKrasOpen separate window Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials MethodsOpen separate windowOpen separate windowOpen separate windowFigure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials MethodsFigure Figure Loss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials MethodsLoss PKC frequent event nonsmall cell lung cancer Analysis publicly available gene expression data sets using NextBio revealed downregulation PKC three major forms NSCLC lung adenocarcinoma squamous cell carcinoma large cell carcinoma progressive advanced tumor stage b Immunohistochemical staining PKC human lung adenocarcinoma adjacent normal lung revealed loss PKC expression tumor tissue Photomicrograph representative three primary lung adenocarcinomas analyzed c Loss PKC observed lung adenomas LSLKras mice Photomicrograph representative tumors tumor bearing LSLKras mice list gene expression data sets analyzed found Materials MethodsabcLSLKrasLSLKrasaPKC inhibits Krasdependent tumor initiation next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shown Open separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N PKC inhibits Krasdependent tumor initiationWe next assessed role PKC loss Kras mediated lung tumorigenesis using mice harboring constitutive deletion Prkc Prkca mice Functional loss PKC confirmed quantitative PCR Figure immunoblot analysis Figure inset lung tissue nontransgenic Ntg heterozygous Prkca homozygous Prkca mice Homozygous Prkca mice crossed LSLKras mice generate bitransgenic LSLKrasPrkca mice Oncogenic Kras expression lung tumorigenesis initiated intratracheal instillation recombinant adenovirus expressing Cre recombinase described previously LSLKrasPrkca mice exhibited significant decrease median survival days compared LSLKras mice days P Figure b Decreased survival correlated significant increase tumor number size burden LSLKrasPrkca mice Figure c assess generality results assessed tumor formation Ntg Prkca mice exposure lung carcinogen urethane Figure Kras LA mice Figure e oncogenic Kras spontaneously activated homologous recombination models PKCdeficiency resulted significant increase tumor number burden Lung tumorigenesis strictly dependent upon carcinogen exposure andor oncogenic Kras activation tumors observed Ntg Prkca mice absence tumor initiators data shownKrasPrkcPrkca Figure aFigure aFigure aFigure aPrkcaPrkcaPrkcaLSLKrasLSLKrasPrkcaKrasLSLKrasPrkcaLSLKrasPFigure bFigure bLSLKrasPrkcaFigure cFigure cPrkcaFigure dFigure dKras LALAFigure eFigure eKrasKrasPrkcaOpen separate window Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Open separate windowOpen separate windowOpen separate windowFigure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Figure Figure Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N Genetic loss PKC stimulates Kras mediated lung tumorigenesis Lungs LSLKras LSLKrasPrkca LSLKrasPrkca mice exhibit progressive loss PKC mRNA Data represent mean mRNA values two mice genotype Inset Immunoblot analysis lung extracts LSLKras LSLKrasPrkca LSLKrasPrkca mice demonstrating loss PKC protein expression Actin served loading control b LSLKrasPrkca mice exhibit decreased survival compared LSLKras tumor induction P N genotype c Gross pathology representative lungs LSLKras LSLKrasPrkca mice demonstrate enhanced tumorigenic phenotype associated PKC loss Quantitative analysis tumor number tumor size tumor burden demonstrate statistically significant increase parameters LSLKrasPrkca mice compared LSLKras mice P N micegenotype PKC loss stimulates urethaneinduced lung tumor number burden P N treatment group e PKC loss stimulates oncogenic Kras LA induced lung tumor number burden P N KrasaLSLKras LSLKrasPrkcaLSLKrasPrkcaLSLKras LSLKrasPrkca LSLKrasPrkcabLSLKrasPrkcaLSLKrasPNcLSLKrasLSLKrasPrkcaLSLKrasPrkcaLSLKrasPNdPNeKras LALAPNLoss PKC induces tumor progression bypass OIS Pathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c Open separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased KiLoss PKC induces tumor progression bypass OISPathological examination revealed significant increase tumor progression LSLKrasPrkca tumors compared LSLKras tumors LSLKrasPrkca mice tumors exhibited nuclear crowding increased mitotic figures nuclear swelling highly variable nuclear morphologies Figure right panel characteristics progression adenoma carcinoma model contrast LSLKras tumors exhibit characteristics classified adenomas Figure left panel Quantitative analysis revealed progression carcinoma LSLKrasPrkca mice LSLKras mice P Fishers exact test LSLKras mice progression carcinoma suppressed due OIS presence oncogenic Kras OIS characterized widespread expression tumor suppressive cell cycle inhibitor p InkA expected LSLKras tumors exhibited widespread OIS evidenced positive staining p relatively low Ki staining Figure c Interestingly LSLKras tumors exhibited regions stained positive PKC p areas expressed low PKC p staining contrast LSLKrasPrkca tumors exhibited uniformly low p expression increased Ki staining consistent OIS bypass increased tumor growth tumor progression Figure c LSLKrasPrkcaLSLKrasLSLKrasPrkcaFigure aFigure aLSLKrasFigure aFigure aLSLKrasPrkcaLSLKrasPLSLKrasKrasInkALSLKrasFigure cFigure cLSLKrasLSLKrasPrkcaFigure cFigure cOpen separate window Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased KiOpen separate windowOpen separate windowOpen separate windowFigure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased KiFigure Figure PKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased KiPKC loss leads tumor progression bypass OIS vivo Histological analysis representative tumors LSLKras LSLKrasPrkca mice demonstrating tumors LSLKrasPrkca mice exhibit characteristic features progression adenoma carcinoma whereas tumors LSLKras mice classified adenomas Arrow large swollen nuclei aberrant nuclear morphology arrowheads nuclear crowding abnormal chromatin condensation Immunohistochemical staining tumors LSLKras b LSLKrasPrkca c mice PKC p Ki LSLKras tumors express abundant p areas tumor PKC expression retained whereas tumors LSLKrasPrkca mice express PKC little p increased Kiin vivoaLSLKrasLSLKrasPrkcaLSLKrasPrkcaLSLKrasLSLKrasbLSLKrasPrkcacLSLKrasLSLKrasPrkcaLoss PKC stimulates Krasmediated BASC expansion PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras Open separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSOLoss PKC stimulates Krasmediated BASC expansionAs PKC inhibits initiation Krasdriven lung tumors hypothesized PKC may inhibit expansion BASCs putative tumorinitiating cells model Therefore quantitated BASCs within terminal bronchioles TB LSLKras LSLKrasPrkca mice vivo described previously expected TB Ntg mice contained either BASCs single BASC Figure Interestingly Prkca mice exhibited change BASC number indicating PKC major factor regulating basal BASC number contrast LSLKras LSLKrasPrkca mice exhibited statistically significant increase BASCs TB exhibiting two BASCs compared Ntg mice Analysis BASC multiplicity demonstrated LSLKrasPrkca mice exhibit significantly larger expansion BASCs LSLKras mice bronchioles higher BASC multiplicity Figure b assess whether difference due direct effect PKC loss BASCs assessed growth isolated BASC cultures ex vivo BASCs isolated purified Ntg Prkca LSLKras LSLKrasPrkca mice described previously treated adenoviral Cre induce oncogenic Kras plated three dimensional Matrigel culture described previously Quantitative analysis BASC colonies grown ex vivo days demonstrate loss PKC little effect BASC colony size absence Kras whereas oncogenic Kras expression resulted significant increase BASC colony size enhanced deletion PKC Figure c similar increase colony size observed BASCs LSLKras mice treated selective PKC inhibitor G Figure indicating effect PKC transformed growth BASCs dependent upon acute PKC kinase activity Thus PKC directly regulates BASC growth presence oncogenic Kras LSLKrasLSLKrasPrkcain vivo Figure aFigure aPrkcaLSLKrasLSLKrasPrkcaLSLKrasPrkcaLSLKrasFigure bFigure bex vivoPrkcaLSLKrasLSLKrasPrkcaKrasex vivoKrasKrasFigure cFigure cLSLKrasFigure dFigure dKrasOpen separate window Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSOOpen separate windowOpen separate windowOpen separate windowFigure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSOFigure Figure PKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSOPKC loss leads expansion Kras transformed BASCs vivo enhanced BASC growth ex vivo Quantitative analysis BASC number vivo TB scored BASCs described Materials Methods results plotted fraction TB either BASCs BASCs LSLKras LSLKrasPrkca mice exhibit increase BASC number compared Ntg Prkca mice P P b BASC multiplicity analysis demonstrates LSLKrasPrkca mice exhibit significantly larger increase BASC expansion LSLKras mice P c Morphology quantitative analysis colony diameter BASCs Ntg Prkca LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture days P compared Ntg P compared LSLKras Effect selective PKC inhibitor Go BASC colony growth BASCs Ntg LSLKras mice grown three dimension culture Matrigel presence Go n diluent DMSO days Representative microphotographs quantitative analysis BASC colony size shown P compared Ntg P compared LSLKras treated DMSOKrasin vivoex vivoain vivoLSLKrasLSLKrasPrkcaPrkcaPPbLSLKrasPrkcaLSLKras micePcPrkcaLSLKrasLSLKrasPrkcaPPLSLKrasdLSLKrasnPPLSLKrasp MAPK downstream effector PKC Krasinduced tumorigenesis p MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progression Open separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotypep MAPK downstream effector PKC Krasinduced tumorigenesisp MAPK key role oncogenic Ras induced senescence p InkA induction p MAPK phosphorylated activated downstream PKC functions tumor promoting suppressive effects PKC Furthermore enhanced lung tumorigenesis observed LSLKrasPrkca mice similar seen p MAPKdeficient mice LSLKras background Therefore assessed whether p MAPK activation modulated PKC BASCs LSLKrasinduced lung tumors Immunoblot analysis revealed decreased phosphop MAPK BASCs LSLKrasPrkca mice compared LSLKras mice Figure effect PKC loss selective phosphop MAPK observed little change either total p MAPK total phosphoErk Figure Addition selective p MAPK inhibitor SB induced enhanced growth BASCs LSLKras mice resulting colonies comparable LSLKrasPrkca mice effect BASCs Ntg LSLKrasPrkca mice Figure b Furthermore LSLKrasPrkca tumors exhibited reduced phosphop MAPK staining compared LSLKras tumors indicating p MAPK activity regulated PKC vivo Figure c Thus p MAPK selectively activated downstream PKC LSLKras induced lung tumorigenesis likely involved PKCmediated inhibition tumor growth progressionRasInkA LSLKrasPrkcaLSLKrasLSLKrasPrkcaLSLKrasFigure aFigure aFigure aFigure aLSLKrasLSLKrasPrkcaLSLKrasPrkcaFigure bFigure bLSLKrasPrkcaLSLKrasin vivoFigure cFigure cLSLKrasOpen separate window Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotypeOpen separate windowOpen separate windowOpen separate windowFigure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotypeFigure Figure p MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotypep MAPK downstream effector PKC Krasmediated BASC expansion Immunoblot analysis total cell lysates BASCs LSLKras LSLKrasPrkca mice phosphop MAPK total p MAPK phosphoErk total Erk b Pharmacologic inhibition p MAPK mimics PKC loss BASC colony growth BASCs Ntg LSLKras LSLKrasPrkca mice grown three dimensional Matrigel culture presence diluent DMSO p MAPKselective inhibitor SB SB stimulates growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs P P P c Immunohistochemical staining tumors normal adjacent lung LSLKras LSLKrasPrkca mice phosphop MAPK LSLKrasPrkca tumors exhibit loss phosphop MAPK compared LSLKras tumors Normal lung epithelium shows low phosphop MAPK staining unaffected genotypeaLSLKrasLSLKrasPrkcabLSLKrasLSLKrasPrkcamLSLKrasLSLKrasPrkcaPPPcLSLKrasLSLKrasPrkcaLSLKrasPrkcaLSLKrasTGF mediates effects PKC loss BASC expansion TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signaling Open separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significantTGF mediates effects PKC loss BASC expansionThe TGF pathway normally tumor suppressive presence oncogenic Ras become prooncogenic Interestingly TGF expression elevated p MAPKdeficient mice expressing oncogenic Kras suggesting PKCp MAPK signaling axis may regulate lung tumorigenesis TGF signaling Consistent possibility quantitative PCR analysis demonstrated small significant increase TGF mRNA expression LSLKrasPrkca BASCs compared LSLKras BASCs Figure addition exogenous TGF led significant increase growth LSLKras BASCs significant effect Ntg LSLKrasPrkca BASCs Figure b addition treatment selective TGFR inhibitor SB blocked growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs Figure c Taken together data demonstrate TGF signaling mediate PKCregulated transformed growth indicate PKC inhibits lung tumor cell growth least part suppressing TGF signalingRasKrasLSLKrasPrkcaLSLKrasFigure aFigure aLSLKrasLSLKrasPrkcaFigure bFigure bLSLKrasPrkcaLSLKrasFigure cFigure cOpen separate window Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significantOpen separate windowOpen separate windowOpen separate windowFigure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significantFigure Figure TGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significantTGF critical mediator inhibitory effects PKC BASC growth TGF expression modestly significantly induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b TGF mimics effects PKC loss BASC colony growth Addition exogenous TGF stimulates growth LSLKras BASC colonies significant effect Ntg LSLKrasPrkca BASCs P P comparisons significant c selective TGF receptor antagonist SB inhibits enhanced growth LSLKrasPrkca BASCs significant effect growth Ntg LSLKras BASCs P compared Ntg DMSO P compared LSLKras DMSO P compared LSLKrasPrkca DMSO comparisons significantaLSLKrasPrkcaLSLKrasNPbLSLKrasLSLKrasPrkcaPPcLSLKrasPrkcaLSLKrasPPLSLKrasPLSLKrasPrkcaPKC regulates expression inhibitors DNA binding Id protein family results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growth Open separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO controlPKC regulates expression inhibitors DNA binding Id protein familyOur results LSLKrasPrkca mice consistent tumor suppressive effect PKC colon colon cancer PKC inhibits cell cycle negatively regulating expression Id family proteins Id Indeed LSLKrasPrkca BASCs express significantly Id Id compared LSLKras BASCs Figure PKCdependent Id gene expression requires p MAPK activity Id mRNA increased LSLKras BASCs treated p MAPK inhibitor SB Figure b Furthermore Id expression significantly decreased LSLKrasPrkca BASCs treated TGFR inhibitor SB Figure c Thus PKC suppresses expression Id family members p MAPKTGF signaling pathway suggesting Id proteins may central players PKCmediated regulation lung tumor growthLSLKrasPrkca LSLKrasPrkcaLSLKrasFigure aFigure aLSLKrasFigure bFigure bLSLKrasPrkcaFigure cFigure cOpen separate window Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO controlOpen separate windowOpen separate windowOpen separate windowFigure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO controlFigure Figure PKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO controlPKC loss induces p MAPK TGFdependent expression Inhibitor DNA binding Id PKC loss leads induction Id Id Id mRNAs Quantitative PCR Id LSLKras LSLKrasPrkca BASCs N P b p MAPK inhibitor SB induces Id expression LSLKras LSLKrasPrkca BASCs N P compared DMSO control c TGFR inhibitor SB reverses Id mRNA induction LSLKrasPrkca BASCs N P compared DMSO controlaLSLKrasLSLKrasPrkcaNPbLSLKrasLSLKrasPrkcaNPcLSLKrasPrkcaNPDeletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesis data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesis Open separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSODeletion PKC induces Wilms Tumor WT Krasinduced lung tumorigenesisOur data demonstrate loss PKC leads bypass OIS tumor progression Figure phenotype strikingly similar seen transgenic mice overexpressing WT gene LSLKras background LSLKrasTg WT mice exhibit enhanced tumorigenesis tumor progression result OIS bypass WT mRNA elevated LSLKrasPrkca BASCs compared LSLKras BASCs Figure b Additionally immunohistochemistry revealed WT elevated LSLKrasPrkca compared LSLKras tumors Figure b treatment LSLKras BASCs p MAPK inhibitor SB led induction WT Figure c Finally WT expression LSLKrasPrkca BASCs reduced treatment TGFR inhibitor SB Figure data consistent role WT facilitating OIS bypass downstream PKC loss lung tumorigenesisFigure Figure LSLKrasLSLKrasTg WTLSLKrasPrkcaBASCsLSLKrasFigure bFigure bLSLKrasPrkcaLSLKrasFigure bFigure bLSLKrasFigure cFigure cLSLKrasPrkcaFigure dFigure dOpen separate window Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSOOpen separate windowOpen separate windowOpen separate windowFigure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSOFigure Figure PKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSOPKC loss induces p MAPK TGFdependent expression WT WT mRNA induced LSLKrasPrkca BASCs compared LSLKras BASCs N P b Immunohistochemical staining WT WT protein elevated LSLKrasPrkca tumors compared LSLKras tumors c p MAPK inhibitor SB preferentially induces WT expression LSLKras BASCs N P compared LSLKras DMSO TGFR inhibitor SB preferentially inhibits WT expression LSLKrasPrkca BASCs N P compared LSLKrasPrkca DMSOaLSLKrasPrkcaLSLKrasNPbLSLKrasPrkcaLSLKrascLSLKrasNPLSLKrasdLSLKrasPrkcaNPLSLKrasPrkcaDISCUSSION PKC family members implicated tumor promotion suppression review see Fields Murray Fields Gustafson conflicting reports regarding role PKCs general PKC specifically tumorigenesis progression disparate results may due differences cell tumortype function results obtained cell lines vitro versus transgenic animal models vivo specificity reagents used identify PKC function demonstrate PKC tumor suppressor vivo using three models Kras mediated lung cancer Genetic loss PKC murine lung results enhanced tumor growth progression carcinoma upon activation oncogenic Kras results consistent progressive loss PKC primary human NSCLC tumors advancing tumor stage PKCs capable phosphorylating Kras leading association mitochondrial BCLXL induction cellular apoptosis interest assess whether mechanism also contributes tumor suppressor effects observed studies focused Kras mediated lung adenocarcinoma human gene expression data indicate PKC frequently lost major forms NSCLC including lung squamous cell carcinoma harbor frequent Kras mutations Likewise PKC tumor suppressive role APC min intestinal tumorigenesis indicating tumor suppressive role PKC extends beyond Kras driven tumors Whether signaling mechanisms involved PKCmediated tumor suppression differ depending upon oncogenic drivers important area future investigation addition role tumor progression animal studies reveal additional unexpected role PKC tumor initiation LSLKrasPrkca mice exhibit enhanced expansion tumorinitiating BASCs effect appears due least part direct effect PKC loss growth Krastransformed BASCs Prkca mice harbor constitutive organismwide loss PKC exclude additional contribution PKC expressed tumorassociated stroma immune cells tumor suppression vivo analysis require complex animal models PKC expression conditionally controlled tissue timespecific manner Mechanistically data indicate PKC key role enforcement OIS vivo LSLKrasPrkca tumors exhibit reduced p InkA expression increase Ki staining progression adenocarcinoma consistent OIS bypass Interestingly observed regional coexpression PKC p InkA LSLKras tumors suggesting PKC loss Kras mediated tumorigenesis may represent intrinsic mechanism tumors overcome OIS findings PKC loss bear striking resemblance observed genetic loss p MAPK suggesting functional link genes Indeed mechanistic studies reveal p MAPK key downstream mediator PKC regulates tumor initiation least part control Kras mediated transformation tumorinitiating BASCs data consistent published reports demonstrating key role p MAPK OIS provide first demonstration PKCp MAPK signaling axis role OIS Kras mediated lung tumorigenesis vivo results also consistent finding PKC regulate senescence lung cancer cell lines vitro results provide compelling evidence PKCp MAPKTGF signaling axis drives tumor suppressive effects PKC Interestingly genetic loss PKC Krastransformed BASCs resulted small highly reproducible increase TGF expression effect though modest functionally relevant exogenous TGF mimic PKC loss inhibition TGF signaling reverses effect PKC loss BASC growth Therefore suppression TGF signaling key mechanism PKC inhibits lung cancer initiation progression Given modest change TGF mRNA abundance PKC likely also regulates aspects TGF signaling lung regard PKC facilitates internalization TGFR cell surface podocytes PKC induces expression TGF TGFR vascular smooth muscle cells data suggest involvement TGFR TGF signaling activation mediated PKC loss treatment TGFRALK selective inhibitor SB inhibits enhanced growth LSLKrasPrkca BASCs TGF like PKC either tumor promoting tumor suppressive depending cellular context Id family genes negativelyregulated PKC colon cancer PKC loss results increased expression Id turn regulate cyclin cell cycle progression Consistent findings show PKC negatively regulates Id BASCs effect PKC Id expression requires novel PKCp MAPKTGF signaling axis characterized report hypothesize PKC functions tumor suppressor lung least part inhibition expression Id genes turn mediate PKCinduced inhibition BASC lung tumor cell growth effect PKC loss Krasinduced lung tumorigenesis reminiscent phenotype observed WToverexpressing mice presence oncogenic Kras WToverexpressing mice exhibit enhanced Kras driven tumorigenesis mice lacking WT exhibit enhanced OIS PKC loss leads increased WT expression p MAPKTGFdependent pathway consistent finding WT expression regulated TGF signaling data suggest WT relevant downstream target involved mediating OIS bypass LSLKrasPrkca mice Analysis gene expression data sets revealed significant inverse relationship PKC WT Id expression primary human NSCLC tumors P Id P WT indicating relevance tumor PKC loss induction WT Id expression primary human NSCLC Finally results important implications therapeutic intervention strategies targeting PKC first isozymeselective PKC inhibitor enter clinical use base antisense oligonucleotide targeting PKC typeentreznucleotideattrstextLYtermid LY Aprinocarsen Aprinocarsen inhibited PKC expression exhibited antitumor activity nude mouse xenograft models However clinical benefit observed phase II clinical trials Aprinocarsen single agent ovarian cancer highgrade glioma Likewise large phase III clinical trial Aprinocarsen combination gemcitabine cisplatin advanced NSCLC failed demonstrate survival benefit difference response Therefore despite encouraging preclinical data PKC successful target cancer treatment current study others cited herein indicate PKC suppresses rather promotes tumorigenesis colon lung calling question rationale PKC inhibitors cancer therapy least tumor typesDISCUSSIONPKC family members implicated tumor promotion suppression review see Fields Murray Fields Gustafson conflicting reports regarding role PKCs general PKC specifically tumorigenesis progression disparate results may due differences cell tumortype function results obtained cell lines vitro versus transgenic animal models vivo specificity reagents used identify PKC function demonstrate PKC tumor suppressor vivo using three models Kras mediated lung cancer Genetic loss PKC murine lung results enhanced tumor growth progression carcinoma upon activation oncogenic Kras results consistent progressive loss PKC primary human NSCLC tumors advancing tumor stage PKCs capable phosphorylating Kras leading association mitochondrial BCLXL induction cellular apoptosis interest assess whether mechanism also contributes tumor suppressor effects observed studies focused Kras mediated lung adenocarcinoma human gene expression data indicate PKC frequently lost major forms NSCLC including lung squamous cell carcinoma harbor frequent Kras mutations Likewise PKC tumor suppressive role APC min intestinal tumorigenesis indicating tumor suppressive role PKC extends beyond Kras driven tumors Whether signaling mechanisms involved PKCmediated tumor suppression differ depending upon oncogenic drivers important area future investigationin vitroin vivoin vivoKrasKrasKrasKrasminKrasIn addition role tumor progression animal studies reveal additional unexpected role PKC tumor initiation LSLKrasPrkca mice exhibit enhanced expansion tumorinitiating BASCs effect appears due least part direct effect PKC loss growth Krastransformed BASCs Prkca mice harbor constitutive organismwide loss PKC exclude additional contribution PKC expressed tumorassociated stroma immune cells tumor suppression vivo analysis require complex animal models PKC expression conditionally controlled tissue timespecific mannerLSLKrasPrkcaPrkcain vivoMechanistically data indicate PKC key role enforcement OIS vivo LSLKrasPrkca tumors exhibit reduced p InkA expression increase Ki staining progression adenocarcinoma consistent OIS bypass Interestingly observed regional coexpression PKC p InkA LSLKras tumors suggesting PKC loss Kras mediated tumorigenesis may represent intrinsic mechanism tumors overcome OIS findings PKC loss bear striking resemblance observed genetic loss p MAPK suggesting functional link genes Indeed mechanistic studies reveal p MAPK key downstream mediator PKC regulates tumor initiation least part control Kras mediated transformation tumorinitiating BASCs data consistent published reports demonstrating key role p MAPK OIS provide first demonstration PKCp MAPK signaling axis role OIS Kras mediated lung tumorigenesis vivo results also consistent finding PKC regulate senescence lung cancer cell lines vitro vivo LSLKrasPrkcaInkAInkALSLKrasKrasKras Krasin vivoin vitroOur results provide compelling evidence PKCp MAPKTGF signaling axis drives tumor suppressive effects PKC Interestingly genetic loss PKC Krastransformed BASCs resulted small highly reproducible increase TGF expression effect though modest functionally relevant exogenous TGF mimic PKC loss inhibition TGF signaling reverses effect PKC loss BASC growth Therefore suppression TGF signaling key mechanism PKC inhibits lung cancer initiation progression Given modest change TGF mRNA abundance PKC likely also regulates aspects TGF signaling lung regard PKC facilitates internalization TGFR cell surface podocytes PKC induces expression TGF TGFR vascular smooth muscle cells data suggest involvement TGFR TGF signaling activation mediated PKC loss treatment TGFRALK selective inhibitor SB inhibits enhanced growth LSLKrasPrkca BASCsLSLKrasPrkcaTGF like PKC either tumor promoting tumor suppressive depending cellular context Id family genes negativelyregulated PKC colon cancer PKC loss results increased expression Id turn regulate cyclin cell cycle progression Consistent findings show PKC negatively regulates Id BASCs effect PKC Id expression requires novel PKCp MAPKTGF signaling axis characterized report hypothesize PKC functions tumor suppressor lung least part inhibition expression Id genes turn mediate PKCinduced inhibition BASC lung tumor cell growth effect PKC loss Krasinduced lung tumorigenesis reminiscent phenotype observed WToverexpressing mice presence oncogenic Kras WToverexpressing mice exhibit enhanced Kras driven tumorigenesis mice lacking WT exhibit enhanced OIS PKC loss leads increased WT expression p MAPKTGFdependent pathway consistent finding WT expression regulated TGF signaling data suggest WT relevant downstream target involved mediating OIS bypass LSLKrasPrkca mice Analysis gene expression data sets revealed significant inverse relationship PKC WT Id expression primary human NSCLC tumors P Id P WT indicating relevance tumor PKC loss induction WT Id expression primary human NSCLCKrasKrasLSLKrasPrkcaPPFinally results important implications therapeutic intervention strategies targeting PKC first isozymeselective PKC inhibitor enter clinical use base antisense oligonucleotide targeting PKC typeentreznucleotideattrstextLYtermid LY Aprinocarsen Aprinocarsen inhibited PKC expression exhibited antitumor activity nude mouse xenograft models However clinical benefit observed phase II clinical trials Aprinocarsen single agent ovarian cancer highgrade glioma Likewise large phase III clinical trial Aprinocarsen combination gemcitabine cisplatin advanced NSCLC failed demonstrate survival benefit difference response Therefore despite encouraging preclinical data PKC successful target cancer treatment current study others cited herein indicate PKC suppresses rather promotes tumorigenesis colon lung calling question rationale PKC inhibitors cancer therapy least tumor typestypeentreznucleotideattrstextLYtermid LYtypeentreznucleotideattrstextLYtermid MATERIALS METHODS Analysis publicly available gene expression data sets PKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo Kras models lung tumorigenesis Three independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use Committee Immunohistochemistry Immunofluorescence LSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKO BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TB BASC isolation ex vivo culture BASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USA Quantitative PCR analysis BASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNA Statistical analysis Differences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier methodMATERIALS METHODSAnalysis publicly available gene expression data sets PKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo Analysis publicly available gene expression data setsPKC WT Id expression assessed publicly available gene expression data sets human NSCLC tumors statistical analyses completed using R Statistical Computing Language Microarray data sets human NSCLC samples normalized using preprocess Core function R program package linear regression modeling conducted determine differentially expressed genes groups Correction multiple testing conducted false discovery rate used cutoff Human microarray data sets accession id typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE typeentrezgeoattrstextGSEtermid GSE available download Gene Expression Omnibus httpwwwncbinlmnihgovgeo typeentrezgeoattrstextGSEtermid GSEtypeentrezgeoattrstextGSEtermidtypeentrezgeoattrstextGSEtermid GSEtypeentrezgeoattrstextGSEtermidtypeentrezgeoattrstextGSEtermid GSEtypeentrezgeoattrstextGSEtermidtypeentrezgeoattrstextGSEtermid GSEtypeentrezgeoattrstextGSEtermidtypeentrezgeoattrstextGSEtermid GSEtypeentrezgeoattrstextGSEtermidtypeentrezgeoattrstextGSEtermid GSEtypeentrezgeoattrstextGSEtermidhttpwwwncbinlmnihgovgeoKras models lung tumorigenesis Three independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use CommitteeKras models lung tumorigenesisThree independent mouse models Krasmediated lung tumorigenesis used analyze role PKC lung cancer development progression first model LSLKras mice CBLJ mated Prkca mice CBLJSV generate bitransgenic LSLKrasPrkca mice Tumorigenesis initiated installation adenoviral Cre recombinase final concentration PFUml intratracheally two l doses weekold mice described previously using Ntg LSLKras Prkca littermates controls second model Kras LA mice CBLJ crossed Prkca mice obtain Kras LA Prkca mice Kras L mice develop lung tumors result spontaneous recombination Kras L allele expression oncogenic Kras described previously Kras L Kras LA Prkca littermates killed weeks age lungs analyzed tumor number burden third model weekold Ntg Prkca mice injected intraperitoneally week weeks mgkg urethane NaCl previously described mice killed weeks cessation urethane exposure lungs harvested assessed tumor number burden experiments used littermates transgenic crosses controls control possible strain differences animal experiments approved Mayo Clinic Institutional Animal Care Use CommitteeLSLKrasPrkcaLSLKrasPrkcaLSLKrasPrkcaKras LALAPrkcaKras LA PrkcaLAKras L ALAKras L ALAKrasKras L ALAKras LA PrkcaLAPrkcaImmunohistochemistry Immunofluorescence LSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKO BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TBImmunohistochemistry ImmunofluorescenceLSLKras LSLKrasPrkca mice sacrificed weeks adenoviral Cre instillation lungs formalinfixed embedded paraffin serially sectioned stained histology immunohistochemical analysis described previously HEstained sections imaged using Aperio ScanScope XT Vista CA USA analyzed using Aperio ImageScope v determine tumor number area burden pathological assessment tumor staging Sections stained PKC Abcam Cambridge USA ab p Santa Cruz Dallas TX USA sc Ki Dako Carpinteria CA USA phosphop MAPK Cell Signaling Danvers USA WT Santa Cruz sc using antibodies diluted PBSTween visualized using Envision Plus Dual Labeled Polymer Kit following manufacturers instructions DAKOLSLKrasLSLKrasPrkca BASCs identified quantitated formalinfixed mouse lung sections described previously number SPC CCSPpositive BASCs per TB determined using ImagePro Plus analyzed statistical significance described previously number mice TB analyzed Figures b c follows Ntg six mice TB LSLKras four mice TB Prkca four mice TB LSLKrasPrkca four mice TB Figures b cFigures b cNtgLSLKrasPrkca LSLKrasPrkcaBASC isolation ex vivo culture BASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USABASC isolation ex vivo cultureex vivoBASCs isolated previously described Isolated BASCs resuspended BEGM Lonza Basel Switzerland media without hydrocortisone containing keratinocyte growth factor ngml PeproTech Rocky Hill NJ USA charcoal stripped fetal bovine serum plated onto Matrigel BD Biosciences San Jose CA USAcoated tissue culture plates Cells incubated adenoviral Cre PFUcell p MAPK inhibitor SB PKC inhibitor Go n recombinant TGF ngml TGFR inhibitor SB indicated figure legends added media h plating media changed every days Brightfield images captured using Olympus Center Valley PA USA IX microscope colony size determined days using ImagePro Plus software Media Cybernetics Rockville MD USAmmQuantitative PCR analysis BASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNAQuantitative PCR analysisBASCs released Matrigel using BD cell recovery solution following manufacturers instructions BD Bioscience Total RNA isolated using RNAqueous Ambion Grand Island NY USA RNA quantity quality assessed using NanoDrop ND spectrophotometer quantitative PCR performed using reagents purchased Applied Biosystems Foster City CA USA detect mouse PKC TGF Id WT using Applied Biosystems Grand Island NY USA ViiA PCR machine Data analyzed using ViiA software mRNA expression normalized RNAStatistical analysis Differences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier methodStatistical analysisDifferences number distribution BASCs assessed using CochraneArmitage test using StatsDirect Cheshire UK Students test oneway ANOVA statistical analyses done using SigmaStat San Jose CA USA P value considered statistically significant Animal survival analyzed using KaplanMeier methodtPACKNOWLEDGEMENTS authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer ResearchACKNOWLEDGEMENTSThe authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer ResearchThe authors thank Brandy Edenfield immunohistochemical staining procedures Capella Weems technical assistance Justin Weems Dr Lee Jamieson animal husbandry members Fields laboratory support encouragement critical review manuscript work supported part grants National Cancer Institute R CA APF R CA NRM APF Monica Flynn Jacoby Endowed Professor Cancer ResearchFootnotes CONFLICT INTEREST authors declare conflict interestFootnotes CONFLICT INTEREST authors declare conflict interest CONFLICT INTEREST authors declare conflict interestCONFLICT INTERESTCONFLICT INTERESTThe authors declare conflict interestREFERENCES Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar REFERENCES Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar Siegel R Naishadham Jemal Cancer statistics CA Cancer J Clin PubMed Google Scholar CA Cancer J Clin CA Cancer J Clin PubMed Google Scholar Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Castagna Takai Kaibuchi K Sano K Kikkawa U Nishizuka Direct activation calciumactivated phospholipiddependent protein kinase tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar Kikkawa U Takai Tanaka Miyake R Nishizuka Protein kinase C possible receptor protein tumorpromoting phorbol esters J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Fields AP Murray NR Protein kinase C isozymes therapeutic targets treatment human cancers Adv Enzyme Regul PMC free article PubMed Google Scholar Adv Enzyme Regul Adv Enzyme Regul PMC free article PMC free articlePubMed Google Scholar Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Cacace Ueffing Philipp Han EK Kolch W Weinstein IB PKC epsilon functions oncogene enhancing activation Raf kinase Oncogene PubMed Google Scholar Oncogene Oncogene PubMed Google Scholar Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar Mischak H Goodnight JA Kolch W MartinyBaron G Schaechtle C Kazanietz MG et al Overexpression protein kinase Cdelta epsilon NIH cells induces opposite effects growth morphology anchorage dependence tumorigenicity J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Ahrens H Simsiman R Tseng CP Zou J et al Transgenic mice overexpressing protein kinase Cdelta epidermis resistant skin tumor promotion Otetradecanoylphorbolacetate Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Reddig PJ Dreckschmidt NE Zou J Bourguignon SE Oberley TD Verma AK Transgenic mice overexpressing protein kinase C epsilon epidermis exhibit reduced papilloma burden enhanced carcinoma formation tumor promotion Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Fields AP Frederick LA Regala RP Targeting oncogenic protein kinase Ciota signalling pathway treatment cancer Biochem Soc Trans Pt PubMed Google Scholar Biochem Soc Trans Pt Biochem Soc Trans PubMed Google Scholar Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Justilien V Fields Atypical PKCs targets cancer therapy Kazanietz editor Protein Kinase C Cancer Signaling Therapy London Springer Google Scholar Protein Kinase C Cancer Signaling Therapy Google Scholar Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Regala RP Weems C Jamieson L Khoor Edell ES Lohse CM et al Atypical protein kinase C iota oncogene human nonsmall cell lung cancer Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar Regala RP Weems C Jamieson L Copland JA Thompson EA Fields AP Atypical protein kinase Ciota plays critical role human lung cancer cell growth tumorigenicity J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Regala RP Davis RK Kunz Khoor Leitges Fields AP Atypical protein kinase Ci required bronchioalveolar stem cell expansion lung tumorigenesis Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar Murray NR Jamieson L Yu W Zhang J GokmenPolar Sier et al Protein kinase Ciota required Ras transformation colon carcinogenesis vivo J Cell Biol PMC free article PubMed Google Scholar J Cell Biol J Cell Biol PMC free article PMC free articlePubMed Google Scholar Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Eder Sui X Rosen DG Nolden LK Cheng KW Lahad JP et al Atypical PKCiota contributes poor prognosis loss apicalbasal polarity cyclin E overexpression ovarian cancer Proc Natl Acad Sci USA PMC free article PubMed Google Scholar Proc Natl Acad Sci USA Proc Natl Acad Sci USA PMC free article PMC free articlePubMed Google Scholar Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Zhang L Huang J Yang N Liang Barchetti Giannakakis et al Integrative genomic analysis protein kinase C PKC family identifies PKCiota biomarker potential oncogene ovarian carcinoma Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar Jamieson L Carpenter L Biden TJ Fields AP Protein kinase Ciota activity necessary BcrAblmediated resistance druginduced apoptosis J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar Murray NR Fields AP Atypical protein kinase Ciota protects human leukemia cells druginduced apoptosis J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Scotti ML Bamlet WR Smyrk TC Fields AP Murray NR Protein kinase C required pancreatic cancer cell transformed growth tumorigenesis Cancer Res PMC free article PubMed Google Scholar Cancer Res Cancer Res PMC free article PMC free articlePubMed Google Scholar Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar Scotti ML Smith KE Butler Calcagno SR Crawford HC Leitges et al Protein kinase Ciota regulates pancreatic acinartoductal metaplasia PLoS One e PMC free article PubMed Google Scholar PLoS One ePLoS One PMC free article PMC free articlePubMed Google Scholar Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Kikuchi K Soundararajan Zarzabal LA Weems CR Nelon LD Hampton ST et al Protein kinase Ciota therapeutic target alveolar rhabdomyosarcoma Oncogene PMC free article PubMed Google Scholar Oncogene Oncogene PMC free article PMC free articlePubMed Google Scholar Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar Erdogan E Lamark StallingsMann Lee J Pellecchia Thompson EA et al Aurothiomalate inhibits transformed growth targeting PB domain protein kinase Ciota J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar StallingsMann Jamieson L Regala RP Weems C Murray NR Fields AP novel smallmolecule inhibitor protein kinase Ciota blocks transformed growth nonsmallcell lung cancer cells Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Nazarenko Jenny Keil J Gieseler C Weisshaupt K Sehouli J et al Atypical protein kinase C zeta exhibits proapoptotic function ovarian cancer Mol Cancer Res PubMed Google Scholar Mol Cancer Res Mol Cancer Res PubMed Google Scholar Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Galvez Duran Linares JF Pathrose P Castilla EA AbuBaker et al Protein kinase Czeta represses interleukin promoter impairs tumorigenesis vivo Mol Cell Biol PMC free article PubMed Google Scholar Mol Cell Biol Mol Cell Biol PMC free article PMC free articlePubMed Google Scholar Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Hsieh YH Wu TT Huang CY Hsieh YS Hwang JM Liu JY p mitogenactivated protein kinase pathway involved protein kinase Calpharegulated invasion human hepatocellular carcinoma cells Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar Tanaka Gavrielides MV Mitsuuchi Fujii Kazanietz MG Protein kinase C promotes apoptosis LNCaP prostate cancer cells activation p MAPK inhibition Akt survival pathway J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Oster H Leitges Protein kinase C alpha PKCzeta suppresses intestinal tumor formation ApcMin mice Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar Oliva JL Caino MC Senderowicz Kazanietz MG Sphasespecific activation PKCa induces senescence nonsmall cell lung cancer cells J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar Nakagawa Oliva JL Kothapalli Fournier Assoian RK Kazanietz MG Phorbol esterinduced G phase arrest selectively mediated protein kinase Cdeltadependent induction p J Biol Chem PubMed Google Scholar J Biol Chem J Biol Chem PubMed Google Scholar Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Jackson EL Willis N Mercer K Bronson RT Crowley Montoya R et al Analysis lung tumor initiation progression using conditional expression oncogenic Kras Genes Dev PMC free article PubMed Google Scholar Genes Dev Genes Dev PMC free article PMC free articlePubMed Google Scholar Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Johnson L Mercer K Greenbaum Bronson RT Crowley Tuveson DA et al Somatic activation Kras oncogene causes early onset lung cancer mice Nature PubMed Google Scholar Nature Nature PubMed Google Scholar Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Nikitin AY Alcaraz Anver MR Bronson RT Cardiff RD Dixon et al Classification proliferative pulmonary lesions mouse recommendations mouse models human cancers consortium Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Collado Serrano Senescence tumours evidence mice humans Nat Rev Cancer PMC free article PubMed Google Scholar Nat Rev Cancer Nat Rev Cancer PMC free article PMC free articlePubMed Google Scholar Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Serrano Lin AW McCurrach Beach Lowe SW Oncogenic ras provokes premature cell senescence associated accumulation p pINKa Cell PubMed Google Scholar Cell Cell PubMed Google Scholar Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Kim CF Jackson EL Woolfenden AE Lawrence Babar Vogel et al Identification bronchioalveolar stem cells normal lung lung cancer Cell PubMed Google Scholar Cell Cell PubMed Google Scholar Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Iwasa H Han J Ishikawa F Mitogenactivated protein kinase p defines common senescencesignalling pathway Genes Cells PubMed Google Scholar Genes Cells Genes Cells PubMed Google Scholar Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Wang W Chen JX Liao R Deng Q Zhou JJ Huang et al Sequential activation MEKextracellular signalregulated kinase MKKp mitogenactivated protein kinase pathways mediates oncogenic rasinduced premature senescence Mol Cell Biol PMC free article PubMed Google Scholar Mol Cell Biol Mol Cell Biol PMC free article PMC free articlePubMed Google Scholar Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Ventura JJ Tenbaum Perdiguero E Huth Guerra C Barbacid et al palpha MAP kinase essential lung stem progenitor cell proliferation differentiation Nat Genet PubMed Google Scholar Nat Genet Nat Genet PubMed Google Scholar Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Grunert Jechlinger Beug H Diverse cellular molecular mechanisms contribute epithelial plasticity metastasis Nat Rev Mol Cell Biol PubMed Google Scholar Nat Rev Mol Cell Biol Nat Rev Mol Cell Biol PubMed Google Scholar Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar Hao F Pysz Curry KJ Haas KN Seedhouse SJ Black AR et al Protein kinase Calpha signaling regulates inhibitor DNA binding intestinal epithelium J Biol Chem PMC free article PubMed Google Scholar J Biol Chem J Biol Chem PMC free article PMC free articlePubMed Google Scholar Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Pysz Leontieva OV Bateman NW Uronis JM Curry KJ Threadgill DW et al PKC tumor suppression intestine associated transcriptional translational inhibition cyclin Exp Cell Res PMC free article PubMed Google Scholar Exp Cell Res Exp Cell Res PMC free article PMC free articlePubMed Google Scholar Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar Vicent Chen R Sayles LC Lin C Walker RG Gillespie AK et al Wilms tumor WT regulates KRASdriven oncogenesis senescence mouse human models J Clin Invest PMC free article PubMed Google Scholar J Clin Invest J Clin Invest PMC free article PMC free articlePubMed Google Scholar Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Fields AP Gustafson WC Protein kinase C disease cancer Methods Mol Biol PubMed Google Scholar Methods Mol Biol Methods Mol Biol PubMed Google Scholar Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Bivona TG Quatela SE Bodemann BO Ahearn IM Soskis MJ Mor et al PKC regulates farnesylelectrostatic switch KRas promotes association BclXL mitochondria induces apoptosis Mol Cell PubMed Google Scholar Mol Cell Mol Cell PubMed Google Scholar Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Tossidou Starker G Kruger J Meier Leitges Haller H et al PKCalpha modulates TGFbeta signaling impairs podocyte survival Cell Physiol Biochem PubMed Google Scholar Cell Physiol Biochem Cell Physiol Biochem PubMed Google Scholar Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Lindschau C Quass P Menne J Guler F Fiebeler Leitges et al Glucoseinduced TGFbeta TGFbeta receptor expression vascular smooth muscle cells mediated protein kinase Calpha Hypertension PubMed Google Scholar Hypertension Hypertension PubMed Google Scholar Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Luo X Ding L Xu J Chegini N Gene expression profiling leiomyoma myometrial smooth muscle cells response transforming growth factorbeta Endocrinology PubMed Google Scholar Endocrinology Endocrinology PubMed Google Scholar Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Dean N McKay R Miraglia L Howard R Cooper Giddings J et al Inhibition growth human tumor cell lines nude mice antisense oligonucleotide inhibitor protein kinase Calpha expression Cancer Res PubMed Google Scholar Cancer Res Cancer Res PubMed Google Scholar Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Geiger Muller Dean NM Fabbro Antitumor activity PKCalpha antisense oligonucleotide combination standard chemotherapeutic agents various human tumors transplanted nude mice Anticancer Drug Des PubMed Google Scholar Anticancer Drug Des Anticancer Drug Des PubMed Google Scholar Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Advani R Peethambaram P Lum BL Fisher GA Hartmann L Long HJ et al phase II trial aprinocarsen antisense oligonucleotide inhibitor protein kinase C alpha administered day infusion patients advanced ovarian carcinoma Cancer PubMed Google Scholar Cancer Cancer PubMed Google Scholar Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar Grossman SA Alavi JB Supko JG Carson KA Priet R Dorr FA et al Efficacy toxicity antisense oligonucleotide aprinocarsen directed protein kinase Calpha delivered day continuous intravenous infusion patients recurrent highgrade astrocytomas Neuro Oncol PMC free article PubMed Google Scholar Neuro Oncol Neuro Oncol PMC free article PMC free articlePubMed Google Scholar Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar PazAres L Douillard JY Koralewski P Manegold C Smit EF Reyes JM et al Phase III study gemcitabine cisplatin without aprinocarsen protein kinase Calpha antisense oligonucleotide patients advancedstage nonsmallcell lung cancer J Clin Oncol PubMed Google Scholar J Clin Oncol J Clin Oncol PubMed Google Scholar Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Dalgaard P Introductory Statistics R nd edition ed New York Springer Google Scholar Introductory Statistics R Google Scholar Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar Smyth GK Limma linear models microarray data Gentleman R Carey V Dudoit Irizarry R W Huber editors Bioinformatics Computational Biology Solutions using R Bioconductor New York Springer pp Google Scholar Bioinformatics Computational Biology Solutions using R Bioconductor Google Scholar Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar SanchezPalencia GomezMorales GomezCapilla JA Pedraza V Boyero L Rosell R et al Gene expression profiling reveals novel biomarkers nonsmall cell lung cancer Int J Cancer PubMed Google Scholar Int J Cancer Int J Cancer PubMed Google Scholar Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar Hou J Aerts J den Hamer B van Ijcken W den Bakker Riegman P et al Gene expressionbased classification nonsmall cell lung carcinomas survival prediction PLoS One e PMC free article PubMed Google Scholar PLoS One ePLoS One PMC free article PMC free articlePubMed Google Scholar Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Dehan E BenDor Liao W Lipson Frimer H Rienstein et al Chromosomal aberrations gene expression profiles nonsmall cell lung cancer Lung Cancer PubMed Google Scholar Lung Cancer Lung Cancer PubMed Google Scholar Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Leitges Plomann Standaert ML Bandyopadhyay G Sajan MP Kanoh et al Knockout PKC alpha enhances insulin signaling PIK Mol Endocrinol PubMed Google Scholar Mol Endocrinol Mol Endocrinol PubMed Google Scholar Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar Fasbender Lee JH Walters RW Moninger Zabner J Welsh MJ Incorporation adenovirus calcium phosphate precipitates enhances gene transfer airway epithelia vitro vivo J Clin Invest PMC free article PubMed Google Scholar J Clin Invest J Clin Invest PMC free article PMC free articlePubMed Google Scholar Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Tuveson DA Shaw Willis NA Silver DP Jackson EL Chang et al Endogenous oncogenic KrasGD stimulates proliferation widespread neoplastic developmental defects Cancer Cell PubMed Google Scholar Cancer Cell Cancer Cell PubMed Google Scholar Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar Malkinson Nesbitt MN Skamene E Susceptibility urethaninduced pulmonary adenomas AJ CBLJ mice use AXB BXA recombinant inbred lines indicating threelocus genetic model J Natl Cancer Inst PubMed Google Scholar J Natl Cancer Inst J Natl Cancer Inst PubMed Google Scholar Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar Regala R Justilien V Walsh MP Weems C Khoor Murray NR et al Matrix metalloproteinase promotes krasmediated bronchioalveolar stem cell expansion lung cancer formation PLoS One e PMC free article PubMed Google Scholar PLoS One ePLoS One PMC free article PMC free articlePubMed Google Scholar Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar Yang Iwanaga K Raso MG Wislez Hanna AE Wieder ED et al Phosphatidylinositol kinase mediates bronchioalveolar stem cell expansion mouse models oncogenic Krasinduced lung cancer One e PMC free article PubMed Google Scholar One eOne PMC free article PMC free articlePubMed Google Scholar Google Scholar Formats PubReader PDF Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Share Permalink Copy RESOURCES Similar articles Cited articles Links NCBI Databases Formats PubReader PDF Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Share Permalink Copy RESOURCES Similar articles Cited articles Links NCBI Databases Formats PubReader PDF Formats PubReader PDF PubReaderPubReaderPDF MPDF Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Actions Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Cite Cite Cite Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Collections Collections Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Add Collections Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Create new collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Add Cancel Create new collection Add existing collection Create new collection Add existing collection Create new collection Create new collection Add existing collection Add existing collection Name collection Name must less characters Choose collection Unable load collection due error Please try Name collection Name must less characters Name collection Name must less characters Choose collection Unable load collection due error Please try Choose collection Unable load collection due error Please try Please try Add Cancel Add Cancel Share Permalink Copy Share Permalink Copy Permalink Copy Permalink Copy Permalink Copy Permalink Copy Copy Copy RESOURCES Similar articles Cited articles Links NCBI Databases RESOURCES Similar articles Cited articles Links NCBI Databases Similar articles Similar articles Similar articles Cited articles Cited articles Cited articles Links NCBI Databases Links NCBI Databases Links NCBI Databases